Mesco Pharmaceuticals Ltd.
Snapshot View

5.17 +0.24 ▲4.9%

05 August 2021, 04:00:00 P.M.
Volume: 100

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mescopharma.com
Financial Indicators
Market Cap 10.51 Cr.
Earnings per share (EPS) 0.00 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 32.75 Trailing Twelve Months Ending 2021-03
Book Value / Share -5.14 Trailing Twelve Months Ending 2021-03
Price to Book Value -1.01 Calculated using Price: 5.17
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 2.03 Cr. 20,320,600 Shares
FaceValue 10
Company Profile
Mesco Pharmaceuticals Ltd is Public Limited Company listed with Bombay Stock Exchange Limited, Calcutta Stock Exchange and Ahmedabad Stock Exchange, established in 1986.

The Company was originally promoted and incorporated as public limited company under the provisions of Companies Act, 1956 under the jurisdiction of Registrar of Companies, Sri Nagar. The Registered office of the Company is shifted from Jammu and Kashmir to Uttar Pradesh on November 10, 1993. At Present the Registered Office of the Company is situated at Upper Kesalton, Tallital, Nainital-263 001, Uttarakhand.

The Company commenced commercial operations in June 1991 by venturing into Seed Marketing of Bulk Drugs and Formalities. However, the operations of the company came to a standstill for more than 15 years due to taking over of the factory building and other assets of the company in Dehradun by UP State Financial Corporation. Though, the Board of the Company is in the process of evaluating alternative business opportunities which the company may choose to enter into the future.

Business area of the company

The company manufactures and distributes a wide range of pharmaceutical products. The Company manufactures bulk drugs and formulations which are sold domestically in India and abroad. However, the business activity of the company was closed since many years. 

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.87%
1 Week
+15.40%
1 Month
+40.11%
3 Month
-10.86%
6 Month
-28.69%
1 Year
-30.60%
2 Year
-56.11%
5 Year
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -11.15 -0.01 -0.01 -357.96
Return on Capital Employed (%) -8.42 -0.01 0.07 -197.61 5.08 -108.57 -36.29 -176.12 -45.82
Return on Assets (%) -8.18 -0.01 0.00 -190.18 3.33 -104.48 -35.22 -165.20 -42.08

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 36 36 36 -10 -10 -10 -11 -11 -11
Non Curr. Liab. 11 11 11 11 10 11 11 11 11
Curr. Liab. 2 1 1 0 0 0 0 0
Minority Int.
Equity & Liab. 48 48 48 1 0 0 0 0 0
Non Curr. Assets 48 48 48 1 0 0 0 0 0
Curr. Assets 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 48 48 48 1 0 0 0 0 0

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales
Other Income 0 0
Total Income 0 0
Total Expenditure -4 -47 0 0 0 0 0
PBIDT -4 0 -47 0 0 0 0 0
Interest 0 0 0
Depreciation
Taxation 1 0
Exceptional Items
PAT -4 -46 0 0 0 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. -2 0 1 0 0 0 0 0 0
Cash Fr. Inv. 5 0
Cash Fr. Finan. -3 0 -1 0 0 0 0 0 0
Net Change 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2018-12 (%) 2019-03 (%) 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%)
Promoter 39.30 39.30 39.30 39.30 39.30 39.30 39.30 39.30 39.30
Public 60.70 60.70 60.70 60.70 60.70 60.70 60.70 60.70 60.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 06 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 please find enclosed the newspaper publication of the Audited Financial Results for the Quarter and Year ended 31st March 2021.
Fri, 02 Jul 2021
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Amendments Regulations 2018
Please find attached the Submission of Half Yearly Disclosure on Related party Transactions under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations 2018 for the Half Year ended 31st March 2021.
Thu, 01 Jul 2021
Results For Quarter And Year Ended 31St March 2021
Pursuant to Regulation 33(3)(d) of SEBI (LODR)Regulations 2015 we hereby confirm and declare that Statutory Auditors of the Company M/S B S Subudhi & Co Chartered Accountants (M.No: 068452) have issued Auditors Report with unmodified opinion in respect of Audited Financial Results for the quarter and year ended on March 31 2021 approved at Board Meeting held on June 30 2021.

Technical Scans View Details

Thu, 05 Aug 2021
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Opening at Low for 3 days Opening at Low for 3 days
Closing Above Previous High Closing Above Previous High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%